DOCSLIB.ORG

Annual Report 2012 ANNUAL REPORT 2012 O Ourshareholders T

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2012 ANNUAL REPORT 2012 O Ourshareholders T T ABLE OF CONTENTS 2 To our shareholders 103 Overall assessment of the 122 Consolidated financial statements 6 100 years of Fresenius business situation 123 Consolidated statement of income 8 Summary of the fiscal year 103 Opportunities and risk report 123 Consolidated statement of 10 Fresenius share 103 Opportunities management comprehensive income 15 Corporate governance declaration 103 Risk management 124 Consolidated statement of and report 104 Risk areas financial position 36 Business segments 111 Assessment of overall risk 125 Consolidated statement of cash flows 36 Fresenius Medical Care 111 Corporate rating 126 Consolidated statement of 40 Fresenius Kabi 111 Subsequent events changes in equity 44 Fresenius Helios 111 Outlook 128 Consolidated segment reporting 48 Fresenius Vamed 112 General and mid-term 130 Notes outlook (see detailed register on page 130) 113 Future markets 131 Gener al notes 113 Economic outlook 149 Notes on the consolidated ANNUAL REPORT 2012 52 Management report 114 Health care sector and statement of income (see detailed register on page 52) markets 154 Notes on the consolidated 53 Operations and business 118 Group sales and earnings statement of financial position environment 118 Sales and earnings by 181 Other notes 53 Group structure and business business segment 205 Notes in accordance with the 57 Corpor ate performance 119 Financing German Commercial Code criteria, goals, and strategy 119 Investments (HGB) 59 Overall business development 120 Procurement 67 Results of operations, financial 120 Research and development position, assets and liabilities 121 Corporate structure and 67 Results of operations organization 207 Auditor’s report 72 Financial position 121 Planned changes in 77 Assets and liabilities human resources and 79 Non-financial performance indicators the social area and other success factors 121 Dividend 208 Report of the Supervisory Board 79 Employees 83 Research and development 214 Boards 88 Procurement 214 Supervisory Board 92 Quality management Fresenius SE & Co. KGaA · Annual Report 2012 96 Responsibility , environmental 216 Management Board management, sustainability Fresenius Management SE KGaA 101 Sales, marketing, 218 Supervisory Board and logistics Fresenius Management SE Co. & SE 219 Glossary 222 Index Fresenius Fresenius T ABLE OF CONTENTS 2 To our shareholders 103 Overall assessment of the 122 Consolidated financial statements 6 100 years of Fresenius business situation 123 Consolidated statement of income 8 Summary of the fiscal year 103 Opportunities and risk report 123 Consolidated statement of 10 Fresenius share 103 Opportunities management comprehensive income 15 Corporate governance declaration 103 Risk management 124 Consolidated statement of and report 104 Risk areas financial position 36 Business segments 111 Assessment of overall risk 125 Consolidated statement of cash flows 36 Fresenius Medical Care 111 Corporate rating 126 Consolidated statement of 40 Fresenius Kabi 111 Subsequent events changes in equity 44 Fresenius Helios 111 Outlook 128 Consolidated segment reporting 48 Fresenius Vamed 112 General and mid-term 130 Notes outlook (see detailed register on page 130) 113 Future markets 131 Gener al notes 113 Economic outlook 149 Notes on the consolidated ANNUAL REPORT 2012 52 Management report 114 Health care sector and statement of income (see detailed register on page 52) markets 154 Notes on the consolidated 53 Operations and business 118 Group sales and earnings statement of financial position environment 118 Sales and earnings by 181 Other notes 53 Group structure and business business segment 205 Notes in accordance with the 57 Corpor ate performance 119 Financing German Commercial Code criteria, goals, and strategy 119 Investments (HGB) 59 Overall business development 120 Procurement 67 Results of operations, financial 120 Research and development position, assets and liabilities 121 Corporate structure and 67 Results of operations organization 207 Auditor’s report 72 Financial position 121 Planned changes in 77 Assets and liabilities human resources and 79 Non-financial performance indicators the social area and other success factors 121 Dividend 208 Report of the Supervisory Board 79 Employees 83 Research and development 214 Boards 88 Procurement 214 Supervisory Board 92 Quality management Fresenius SE & Co. KGaA · Annual Report 2012 96 Responsibility , environmental 216 Management Board management, sustainability Fresenius Management SE KGaA 101 Sales, marketing, 218 Supervisory Board and logistics Fresenius Management SE Co. & SE 219 Glossary 222 Index Fresenius Fresenius F INANCIAL CALENDAR Report on 1st quarter 2013 Conference call, Live webcast April 30, 2013 Annual General Meeting, Frankfurt am Main, Germany May 17, 2013 FRESENIUS medical care FRESENIUS KABI Payment of dividend 1 May 20, 2013 Report on 1st half 2013 Conference call, Live webcast July 30, 2013 DIALYSIS products, INFUSION THERAPY, IV DRUGS, Report on 1st – 3rd quarters 2013 DIALYSIS care CLINICAL NUTRITION, Conference call, Live webcast November 5, 2013 Medical DEVICES / 1 Subject to prior approval by the Annual General Meeting TRANSFUSION technologY FRESENIUS group IN FIGURES (U.S. GAAP) 2012 2011 2012 2011 € in millions 2012 2011 2010 2009 2008 US$ in millions US$ in millions Change € in millions € in millions Change Sales and Earnings Sales 13,800 12,571 1 10% 4,539 3,964 15% Sales 19,290 16,361 1 15,972 14,164 12,336 EBIT 2,329 2 2,075 12% 934 803 16% EBITDA 3,851 2 3,237 3,057 2,616 2,260 3 Net income 3 1,118 2 1,071 4% 444 354 25% FRESENIUS SHARE / ADR EBIT 3,075 2 2,563 2,418 2,054 1,727 3 Operating cash flow 2,039 1,446 41% 596 462 29% 4 Net income (before special items) 938 770 660 514 450 Capital expenditure / Ordinary share ADR Depreciation and amortization 776 674 639 562 783 acquisitions 2,561 2,614 - 2% 1,153 188 -- Securities identification no. 578 560 CUSIP 35804M105 Earnings per share in € (before special items) 4 5.42 4.73 4.08 3.18 2.85 R & D expenses 112 111 1% 194 162 20% Ticker symbol FRE Ticker symbol FSNUY Cash flow and Balance sheet Employees (December 31) 90,866 83,476 9% 30,214 24,106 25% ISIN DE0005785604 ISIN US35804M1053 Operating cash flow 2,438 1,689 1,911 1,553 1,074 Bloomberg symbol FRE GR Structure Sponsored Level 1 ADR Operating cash flow in % of sales 12.6% 10.3% 12.0% 11.0% 8.7% Reuters symbol FREG.de Ratio 8 ADR = 1 Share Total assets 30,664 26,321 23,577 20,882 20,544 Main trading location Frankfurt / Xetra Trading location OTC-market Non-current assets 22,551 19,170 17,142 15,519 15,466 FRESENIUS HELIOS FRESENIUS VAMED Equity 5 12,758 10,577 8,844 7,491 6,943 Net debt 10,143 9,164 8,015 7,879 8,417 Net debt / EBITDA 2.6 6 2.8 2.6 3.0 3.6 7 Hospital operation ENGINEERING AND Services Equity ratio 5 42% 40% 38% 36% 34% Corporate Headquarters Postal address Contact for shareholders Contact for journalists FOR hospitals AND Investments 8 4,179 2,395 1,402 931 4,617 Else-Kröner-Straße 1 Fresenius SE & Co. KGaA Investor Relations Corporate Communications OTHER health care facilities Bad Homburg v. d. H. 61346 Bad Homburg v. d. H. Telephone: ++ 49 61 72 6 08-26 37 Telephone: ++ 49 61 72 6 08-23 02 Profitability Germany Germany Telefax: ++ 49 61 72 6 08-24 88 Telefax: ++ 49 61 72 6 08-22 94 EBIT margin 15.9% 2 15.7% 15.1% 14.5% 14.0% 3 e-mail: [email protected] e-mail: [email protected] 4 7 2012 2011 2012 2011 Return on equity after taxes (ROE) 12.3% 12.9% 13.3% 12.1% 10.5% € in millions € in millions Change € in millions € in millions Change 2 7 Return on operating assets (ROOA) 11.0% 10.9% 11.6% 10.5% 9.8% Sales 3,200 2,665 20% 846 737 15% 2 7 Return on invested capital (ROIC) 9.0% 8.8% 8.9% 8.2% 7.3% EBIT 322 270 19% 51 44 16% 9 Dividend per share in € 1.10 0.95 0.86 0.75 0.70 Net income 3 203 163 25% 35 34 3% Commercial Register: Bad Homburg v. d. H.; HRB 11852 Employees (December 31) 169,324 149,351 137,552 130,510 122,217 Operating cash flow 240 294 - 18% 35 - 83 142% Chairman of the Supervisory Board: Dr. Gerd Krick 1 2011 sales were adjusted by - € 161 million according to a U.S. GAAP accounting change. This solely relates to Fresenius Medical Care North America. Capital expenditure / General Partner: Fresenius Management SE 2 2012 adjusted for one-time costs (€ 6 million) related to the offer to the shareholders of RHÖN-KLINIKUM AG as well as for other one-time costs (€ 86 million) acquisitions 759 202 -- 55 10 -- Registered Office and Commercial Register: Bad Homburg v. d. H.; HRB 11673 at Fresenius Medical Care. Management Board: Dr. Ulf M. Schneider (President and CEO), Dr. Francesco De Meo, Dr. Jürgen Götz, Mats Henriksson, Rice Powell, Stephan Sturm, Dr. Ernst Wastler 3 Order intake n / a n / a 657 604 9% 2008 adjusted for special items relating to the acquisition of Fresenius Kabi USA (formerly APP Pharmaceuticals) of the business segments figures Key Chairman of the Supervisory Board: Dr. Gerd Krick 4 Net income attributable to shareholders of Fresenius SE & Co. KGaA, 2012 adjusted for a non-taxable investment gain (€ 34 million) and other one-time costs Employees (December 31) 42,881 37,198 15% 4,432 3,724 19% (€ 17 million) at Fresenius Medical Care as well as for one-time costs (€ 29 million) related to the offer to the shareholders of RHÖN-KLINIKUM AG. < The German version of this Annual Report is legally binding.
Load more

Recommended publications
  • Credit Insurance Market Survey
    CREDIT INSURANCE MARKET SURVEY 2 01 9 CREDIT INSURANCE MARKET 2019 INSURERS & SHARES MARKET SHARE The trade credit insurance market remains very 2018 (source: www.icisa.org). Euler Hermes remains the oligopolistic and the Top 3 «global» insurers represent leading credit insurance carrier with 34.1% of market more than 75% of the total premium. ICISA estimates share followed by Atradius 24.6%, and Coface with a total market size around €6.7 billion in premium in 17.1% as of December 31st 2018. 17,3% 34,1% • Euler Hermes 24,3% • Atradius 24,6% • Others • Coface This calculation is an estimate by AU Group, excluding China Export insurance company which achieved a turnover of approximatively & Credit Insurance Corporation (“Sinosure”), the public Chinese €1.4 bn (2016 figures, total short term premium). TYPES OF INSURERS The International Credit Insurer & Surety Association “Niche” insurers, characterised by expertise in: (ICISA) comprises more than 50 members that provide ➤ particular products: Excess of loss, shared excess Trade Credit Insurance535 402 across the world. However, two cover, top-up, single risk (e.g.: AIG, Chubb, Garant, Nexus, main categories of insurers can be distinguished: “Global” 600000 466 379 Liberty Mutual, Lloyd’s, Markel, QBE, Tokio Marine, XL and “Niche” insurers. Catlin, Zurich etc.) 500000 335 270 ➤ certain geographical areas (e.g.: ATI, Cesce, Credendo, “Global” insurers, characterised by: FCIA, ICIC, QBE, Sace etc.) 400000 ➤ a strong international presence ➤ different types of risk: political risk, non-transfer 300000➤ detailed information on a very large number of buyers (e.g.: Garant, Beazley, Liberty Mutual, Lloyd’s, Zurich...) in their global databases • Atradius 200000➤ global capabilities in providing credit• Coface management services • Euler Hermes 100000 Leading insurers in this category are: Atradius, Coface, Euler 0Hermes.
    [Show full text]
  • EH Re AG) in Its Financial Statements (For 2018 Results: 1 EUR= 1.1269 CHF, for 2017 Results: 1 EUR = 1.17015177 CHF)
    Euler Hermes Reinsurance AG Financial Condition Report Based on 31/12/2018 figures Financial Condition Report of Euler Hermes Re AG 2018 Contents Contents ........................................................................................................................... 1 Executive Summary .......................................................................................................... 1 Business activities (A) ............................................................................................................... 1 Company success (B) ................................................................................................................ 2 Governance and risk management (C) ...................................................................................... 2 Risk profile (D) ......................................................................................................................... 3 Valuation (E) ............................................................................................................................ 3 Capital management & Solvency requirements (F&G) ............................................................... 3 A. Business activities ...................................................................................................... 4 A.1. Business overview ......................................................................................................... 4 A.1.1. Business overview .......................................................................................................................
    [Show full text]
  • Das Nachhaltigkeitsrating Der Oekom Research AG
    Das Nachhaltigkeitsrating der oekom research AG Reinhold Windorfer, Analyst TUM Vorlesung Umweltmanagement, 18. Juli 2011 Seite 1 über uns – Corporate & Country Research – Universum umfasst int. wichtigste Aktien und Renten – höchste Qualitätsstandards – Anzahl der Mitarbeiter: 39 – interdisziplinäres 27-köpfiges Analystenteam – Wissenschaftlicher Beirat – Partner von verschiedenen Asset Managern und institu- tionellen Investoren in AT, CH, DE, FR, IE, IT, JP, US – Einfluss auf Fonds und Mandate mit Gesamtvolumen von EUR 90 Mrd. (Dezember 2010) – Markterfahrung seit 1993 – völlige Unabhängigkeit – entstanden aus oekom verlag Seite 3 referenzen Auszug aus unserer Kundenliste Asset Manager, Banken, Fondsgesellschaften Allianz Global Investors France Kaiser Partner AGICAM KD-Bank AmpegaGerling Investment Kepler Fonds Amundi Asset Management Landesbank Baden-Württemberg AXA Investment Managers LBBW Asset Management Baden-Württembergische Bank LIGA Bank Institutionelle Investoren Bank für Orden und Mission MEAG Bank für Sozialwirtschaft Metzler Bayerische Versorgungskammer Bankhaus Jungholz Metzler Asset Management Deutsche Bundesstiftung Umwelt Bankhaus Schelhammer & Schattera Natixis Asset Management Diözese Linz Bank Vontobel NORD/LB Kapitalanlagegesellschaft Diözese Rottenburg-Stuttgart BayernInvest ÖkoWorld Lux Etablissement de Retraite Additionnelle de la BNP Paribas Asset Management Pioneer Investments Fonction Publique (ERAFP) BÖAG Börsen AG Hamburg/Hannover Proventus Evangelisch-Lutherische Kirche in Bayern CM-CIC Asset Management quirin
    [Show full text]
  • These Comments Are Submitted by Allianz of America,1 Munich
    a ALLIANZ OF AMERICA CORPORATION MUNICH REINSURANCE AMERICA CORPORATION SWISS RE AMERICA HOLDING CORPORATION These comments are submitted by Allianz of America,1 Munich Reinsurance America,2 and Swiss Re America.3 For the past three years, the Administration’s Budget has included a proposal to deny the deduction for property-casualty reinsurance premiums placed with a foreign affiliate by a U.S. insurer.4 The Administration proposal was introduced in the 112th Congress by Rep. Richard Neal (H.R. 3157) and by Sen. Robert Menendez (S. 1693). These comments demonstrate that the Administration proposal would disrupt essential risk distribution practices followed by domestic and foreign insurers, alike; increase premiums and reduce coverage available to U.S. consumers, particularly in catastrophe prone areas along the coastlines; and violate U.S tax treaty obligations and commitments to the World Trade Organization. In addition, the Administration errs in characterizing routine affiliate transactions with treaty partners with significant corporate tax regimes as erosion of the U.S. tax base. BACKGROUND Under current law, a U.S. insurer may deduct the premium for reinsurance placed with another company, whether affiliated, unaffiliated, domestic or foreign. A current deduction for this crucial expense ensures that there is a proper matching of income and expense. The U.S. insurer will include in income any ceding commission received from the reinsurer, and, when it 1 Allianz S.E., a German company, owns Fireman’s Fund Insurance Company, Allianz Global Corporate and Specialty Insurance, Euler Hermes-USA, and Allianz Global Assistance –USA. Together, Allianz’s property- casualty insurance subsidiaries in the U.S.
    [Show full text]
  • Euler Hermes Group Announces CEO Leadership Change
    Euler Hermes Group announces CEO leadership change ● Wilfried Verstraete to step down as CEO on December 31st, 2020 ● Clarisse Kopff is appointed CEO of Euler Hermes Group starting January 1st, 2021 ● Wilfried Verstraete remains as advisor to the new CEO though 2021 PARIS, 1 October 2020 – Euler Hermes Group, the worldwide leader in trade credit insurance, announces today that Wilfried Verstraete, CEO and Chairman of the Board of Management has decided to step down from his operational duties after twelve successful years in the role. Clarisse Kopff will succeed him as CEO and Chairperson of the Board of Management as of January 1st, 2021. The change is subject to regulatory approval. Wilfried Verstraete joined Euler Hermes in 2009 where he steered the group through the global financial crisis. Under his leadership, he transformed the traditional, century-old credit insurer into a data-driven, customer-centric Fintech leader with market leading, real-time digital solutions for its clients. He will continue to serve Euler Hermes Group as an advisor to the new CEO through 2021. He will also retain board positions in Euler Hermes SA, Euler Hermes North America, Solunion and Euler Hermes Reinsurance AG. Clarisse Kopff (47) is a graduate of ESCP Business School and holds a postgraduate degree from Université Paris Dauphine and the German Diplom Kaufmann. She is currently Chief Financial Officer of Allianz France. She began her career in debt origination at Lehman Brothers in London, then as an auditor with PricewaterhouseCoopers in Paris before joining Euler Hermes in 2001 as controller for the company’s French entity in Paris.
    [Show full text]
  • 2013 Consolidated Financial Statement and Management Report
    2013 Consolidated Financial Statements and Management Report of Fresenius SE & Co. KGaA, Bad Homburg v. d. H. at December 31, 2013 applying Section 315a HGB in accordance with International Financial Reporting Standards TABLE OF CONTENTS 2 Fundamental information about the Group 38 Outlook 2 The Group‘s business model 38 General and mid-term outlook 3 Management and control 39 Future markets 3 Key products and services 40 Health care sector and markets 4 Important markets and competitive position 42 Group sales and earnings 4 Legal and economic factors 43 Sales and earnings by business segment 4 Capital, shareholders, articles of association 44 Financing 5 Goals and strategy 44 Investments 6 Corporate performance criteria 44 Procurement 7 Research and development 44 Research and development 10 Employees 45 Corporate structure and organization 12 Procurement 45 Planned changes in human resources and the social area 14 Quality management 45 Dividend 16 Responsibility, environmental management, sustainability 19 Sales, marketing, and logistics 46 Opportunities and risk report 46 Opportunities management 20 Report on economic position 46 Risk management 20 Health care industry 47 Risk areas 20 The dialysis market 54 Assessment of overall risk 22 The market for infusion therapy and clinical nutrition, intra- venously administered drugs, medical devices, and transfu- sion technology 55 Consolidated financial statements 23 The German hospital market 56 Consolidated statement of income 24 The market for projects and services for hospitals and
    [Show full text]
  • New Report Finds a Strong Economic Recovery Requires A
    PRESS RELEASE Princeton, NJ July 13, 2020 NEW REPORT FINDS A STRONG ECONOMIC RECOVERY REQUIRES A HEALTHY TRADE CREDIT INSURANCE INDUSTRY Report commissioned by leading trade credit insurers proposes government reinsurance policy to support U.S. economy As economic uncertainty due to COVID-19 continues to impact businesses across the country, a new report commissioned by trade credit insurers Euler Hermes, Coface and Atradius found that a lack of support for the trade credit insurance (TCI) industry could disrupt the stability of millions of businesses across the U.S. The report, titled “A Strong Recovery Requires a Healthy Trade Credit Insurance Industry,” outlines the importance of trade credit insurance to the economy, the significant cutbacks in TCI coverage that the COVID pandemic has caused, and the reasons why government support for the TCI industry is vital to the continuity of economic activity. The report conservatively concludes that in the absence of a government response, the cutbacks in coverage will inhibit $46 billion in additional production and the creation of approximately 155,000 U.S. jobs at supplier firms, with additional effects on downstream buyers. Euler Hermes, Coface and Atradius are the world’s three largest trade credit insurers, representing about 60% of the market in the U.S. Last month, the three companies formed a working group to educate the public and the U.S. government on the essential role trade credit insurance plays in supporting U.S. businesses and the economy at large. Statement from James Daly, CEO of Euler Hermes North America, Oscar Villalonga, President and CEO at Coface North America, and Gordon Cessford, President and Regional Director for North America at Atradius: It is not often that you see the main players in a single industry, typically competitors, come together for a common purpose of public interest.
    [Show full text]
  • Press Release
    Press release Solunion, joint venture of Euler Hermes and MAPFRE, named best trade credit insurer by ADECOSE MADRID – 8 APRIL 2014 - Solunion, joint venture of Euler Hermes and MAPFRE, was recognized by ADECOSE as the best trade credit insurance company in Spain. ADECOSE is an independent Spanish association founded in 1977 to support the interests of insurance brokers - while respecting and consolidating the values of freedom, independence, objectivity, and ethics - and to provide services to associate members. “This recognition by the ADECOSE study participants highlights the relevance of our offer, our multichannel distribution and our overall competitive position in the market,” said Pascal Personne, CEO of Solunion España. “It further encourages us in our strategy of being the preferred partner for our distribution channel, particularly for brokers.” The ADECOSE barometer, presented in Madrid, is designed to showcase excellence within the business insurance sector and the quality of the services notably for brokers. Ninety-six brokers, representing over 84% of association members, offered their insights in 753 interviews. # # # Media Contacts Euler Hermes Group Media Relations Publicis Consultants Remi Calvet– +33(0)1 84 11 61 41 Romain Sulpice +33 (0)1 44 82 46 21 [email protected] [email protected] Solunion Communication Department Eva Muñoz +34 91 417 80 11 [email protected] Euler Hermes is the global leader in trade credit insurance and a recognized specialist in the areas of bonding, guarantees and collections. With more than 100 years of experience, the company offers business-to-business (B2B) clients financial services to support cash and trade receivables management.
    [Show full text]
  • Multi-Generational Families, Single-Parent Families, Same-Sex Couple Families, Blended Families, Older Parent with Young Children Families, and Boomerang Families
    The Allianz LoveFamilyMoney® Study Changing family dynamics create new financial needs How the evolution of the American family is creating new challenges – and revealing new opportunities – for the financial services industry ENT-1677 Page 1 of 16 Study overview Over the past 40 years, shifting demographics and profound attitudinal changes have helped redefine the concept of “family” for many Americans. In fact, the very structure of the American family is changing dramatically: According to the U.S. Census Bureau, almost half of adults today do not live with a spouse – compared to approximately 30% in 1967.1 To understand how this evolving family structure is changing Americans’ relationship with money and financial planning, Allianz commissioned the 2014 LoveFamilyMoney study. The study sought to explore exactly how American families are changing, and to answer one fundamental question: “How does the evolving family structure change Americans’ relationship with money and financial services?” This white paper summarizes the study’s key findings. Today’s modern family Families today come in so many shapes and sizes that there is no longer a single definition of what constitutes a “modern family.” But although the definition of family may be both broad and diverse, the Allianz LoveFamilyMoney Study identified six distinct modern family types2 with unique characteristics: multi-generational families, single-parent families, same-sex couple families, blended families, older parent with young children families, and boomerang families. We also surveyed traditional family households so we could compare their responses. 1 U.S. Census Bureau, Current Population Survey Annual Social and Economic Supplement, 1967 – 2015. 2 For the purposes of our study, a type is defined as a group or social class.
    [Show full text]
  • 43 List of Participations of the Allianz Group As of 31 December 2017 According to § 313 (2) HGB
    D _ Consolidated Financial Statements 43 _ List of participations of the Allianz Group as of 31 December 2017 according to § 313 (2) HGB % % % owned1 owned1 owned1 Allianz Leben Private Equity Fonds 2008 GmbH, APK Infrastrukturfonds GmbH, Munich 100.0 GERMANY Munich 100.0 APK-Argos 75 Vermögensverwaltungs- Consolidated affiliates Allianz Leben Private Equity Fonds Plus GmbH, gesellschaft mbH, Munich 100.0 Munich 100.0 abracar GmbH, Munich 100.0 APK-Argos 85 Vermögensverwaltungs- ACP GmbH & Co. Beteiligungen KG II, Munich 0.0 2 Allianz Lebensversicherungs-Aktiengesellschaft, gesellschaft mbH, Munich 100.0 Stuttgart 100.0 APKV Direkt Infrastruktur GmbH, Munich 100.0 ACP Vermögensverwaltung GmbH & Co. KG 3 Allianz LFE Fonds, Frankfurt am Main 100.0 Nr. 4, Munich 100.0 APKV Infrastrukturfonds GmbH, Munich 100.0 Allianz L-PD Fonds, Frankfurt am Main 100.0 3 ACP Vermögensverwaltung GmbH & Co. KG APKV Private Equity Fonds GmbH, Munich 100.0 Nr. 4a, Munich 100.0 Allianz of Asia-Pacific and Africa GmbH, Munich 100.0 APKV-Argos 74 Vermögensverwaltungs- ACP Vermögensverwaltung GmbH & Co. KG Allianz Pension Direkt Infrastruktur GmbH, gesellschaft mbH, Munich 100.0 Nr. 4c, Munich 100.0 Munich 100.0 APKV-Argos 84 Vermögensverwaltungs- ACP Vermögensverwaltung GmbH & Co. KG Allianz Pension Partners GmbH, Munich 100.0 gesellschaft mbH, Munich 100.0 Nr. 4d, Munich 100.0 Allianz Pension Service GmbH, Munich 100.0 ARE Funds APKV GmbH, Munich 100.0 ADEUS Aktienregister-Service-GmbH, Munich 79.6 Allianz Pensionsfonds Aktiengesellschaft, ARE Funds AZL GmbH,
    [Show full text]
  • Financial Report 2008 Financial Report 2008
    Financial Report 2008 Financial Report 2008 Financial Calendar 2009 Apr 28, 2009 Interim Report as of March 31, 2009 May 26, 2009 Annual General Meeting in the Festhalle Frankfurt am Main (Exhibition Center) May 27, 2009 Dividend payment Jul 29, 2009 Interim Report as of June 30, 2009 Oct 29, 2009 Interim Report as of September 30, 2009 2010 Feb 4, 2010 Preliminary results for the 2009 financial year Mar 12, 2010 Annual Report 2009 and Form 20-F Apr 27, 2010 Interim Report as of March 31, 2010 May 27, 2010 Annual General Meeting in the Festhalle Frankfurt am Main (Exhibition Center) May 28, 2010 Dividend payment Jul 28, 2010 Interim Report as of June 30, 2010 Oct 28, 2010 Interim Report as of September 30, 2010 Deutsche Bank Deutsche Bank The Group at a Glance 2008 2007 Share price at period end € 27.83 € 89.40 Share price high € 89.80 € 118.51 Share price low € 18.59 € 81.33 Basic earnings per share € (7.61) € 13.65 1 Diluted earnings per share € (7.61) € 13.05 Average shares outstanding, in m., basic 504 474 Average shares outstanding, in m., diluted 504 496 Return on average shareholders’ equity (post tax) (11.1) % 17.9 % Pre-tax return on average shareholders’ equity (16.5) % 24.1 % 2 Pre-tax return on average active equity (17.7) % 29.0 % Book value per basic share outstanding3 € 52.59 € 79.32 4 Cost/income ratio 134.6 % 69.6 % Compensation ratio5 71.2 % 42.7 % 6 Noncompensation ratio 63.4 % 26.9 % in € m.
    [Show full text]
  • Change in Substantial Holding
    604 page 1/2 15 July 2001 Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder To Company Name/Scheme STARPHARMA HOLDINGS LIMITED ACN/ARSN 078532180 1. Details of substantial holder(1) Name Allianz SE and the entities listed in the Appendix A ACN/ARSN (if applicable) N/A There was a change in the interests of the substantial holder on 06 / 10 / 2020 The previous notice was given to the company on 21 / 05 / 2020 The previous notice was dated 21 / 05 / 2020 2. Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows: Class of securities (4) Previous notice Present notice Person's votes Voting power (5) Person's votes Voting power (5) Ordinary shares 18,648,131 5.01% 28,632,065 7.11% 3. Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of Person whose Nature of Consideration Class and Person's votes change relevant interest change (6) given in relation number of affected changed to change (7) securities affected See Appendix B 4.
    [Show full text]